Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
|
|
UN Integrated Regional Information Networks - October 11, 2001
Melcome managing director Samar Kumar Mukherjee was reported as saying that the drugs were the cheapest on the market and were going for between US $40 and US $45 per month. He said this meant infected people would spend between US $1.80 to US $2 per day. "These are the cheapest drugs on the market, such that every person including those from lower society, would benefit from," he was quoted as saying.
The report listed the drugs as Avalam 150 which contains Lamivudine, Nevipan containing Nevirapine, Aviro-Z with Zidovudine and Avocomb containing a combination of Lamivudine and Zidovudine. Launching the drugs, Mumba was reported as saying that guidelines on usage had been developed by the government and were awaiting implementation. Mumba challenged the private sector to contribute to the development of an infrastructure in the fight against AIDS.
"The government is committed to ensuring the disease is combated. All sectors of society need to be involved in this fight," he said.
According to Mumba, about 20 percent of the people in the country were infected by HIV/AIDS, a figure representing about two million people. Mumba said the percentage might appear small, but it was high with regard to a growing population. "In Zambia, AIDS is not just a health crisis but a threat to the development of society. Not only does it stagnate the present but also the future," he was quoted as saying.
011011
IR011019
Copyright © 2001 - Integrated Regional Information Networks (IRIN). Reproduction of this article (other than one copy for personal reference) must be cleared through the Integrated Regional Information Network. .
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980 – 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .